Trial Outcomes & Findings for Assessing Fitting Guides in Alcon Multifocal Contact Lenses (NCT NCT03118934)

NCT ID: NCT03118934

Last Updated: 2018-09-26

Results Overview

The Investigator used a multi-focal contact lens fitting guide to determine which study lens to fit

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

188 participants

Primary outcome timeframe

VIsit 1/Day 1

Results posted on

2018-09-26

Participant Flow

Subjects were recruited from 20 investigational sites located in the United States (14), United Kingdom (3), and Canada (3).

Of the 188 enrolled subjects, 6 were exited prior to trial fit. This reporting group includes all subjects randomized and trial fit, as randomized (182). Safety Analysis Set is reported as exposed.

Participant milestones

Participant milestones
Measure
AOA MF - Alternative
Bilaterally (in both eyes) fitted using alternative fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally for 10 ± 3 days
DACP MF - Alternative
Bilaterally fitted using alternative fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
DT1 MF - Alternative
Bilaterally fitted using alternative fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
AOA MF - Current
Bilaterally fitted using current fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally (in both eyes) for 10 ± 3 days
DACP MF - Current
Bilaterally fitted using current fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
DT1 MF - Current
Bilaterally fitted using current fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
Overall Study
STARTED
34
31
34
29
29
25
Overall Study
Safety Analysis Set
34
29
34
29
26
25
Overall Study
COMPLETED
34
30
33
28
27
23
Overall Study
NOT COMPLETED
0
1
1
1
2
2

Reasons for withdrawal

Reasons for withdrawal
Measure
AOA MF - Alternative
Bilaterally (in both eyes) fitted using alternative fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally for 10 ± 3 days
DACP MF - Alternative
Bilaterally fitted using alternative fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
DT1 MF - Alternative
Bilaterally fitted using alternative fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
AOA MF - Current
Bilaterally fitted using current fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally (in both eyes) for 10 ± 3 days
DACP MF - Current
Bilaterally fitted using current fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
DT1 MF - Current
Bilaterally fitted using current fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
Overall Study
Adverse Event
0
0
0
0
0
1
Overall Study
Physician Decision
0
0
0
0
0
1
Overall Study
Discontinued prior to exposure
0
1
1
1
2
0

Baseline Characteristics

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
AOA MF
n=63 Participants
Lotrafilcon B multifocal contact lenses worn bilaterally for 10 ± 3 days
DACP MF
n=55 Participants
Nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
DT1 MF
n=59 Participants
Delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
Total
n=177 Participants
Total of all reporting groups
Age, Continuous
50.6 years
STANDARD_DEVIATION 6.9 • n=5 Participants
50.1 years
STANDARD_DEVIATION 6.7 • n=7 Participants
50.1 years
STANDARD_DEVIATION 6.7 • n=5 Participants
50.3 years
STANDARD_DEVIATION 6.7 • n=4 Participants
Sex: Female, Male
Female
51 Participants
n=5 Participants
46 Participants
n=7 Participants
52 Participants
n=5 Participants
149 Participants
n=4 Participants
Sex: Female, Male
Male
12 Participants
n=5 Participants
9 Participants
n=7 Participants
7 Participants
n=5 Participants
28 Participants
n=4 Participants
Race/Ethnicity, Customized
White
55 Participants
n=5 Participants
48 Participants
n=7 Participants
51 Participants
n=5 Participants
154 Participants
n=4 Participants
Race/Ethnicity, Customized
Black or African American
2 Participants
n=5 Participants
4 Participants
n=7 Participants
0 Participants
n=5 Participants
6 Participants
n=4 Participants
Race/Ethnicity, Customized
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race/Ethnicity, Customized
Asian
5 Participants
n=5 Participants
2 Participants
n=7 Participants
6 Participants
n=5 Participants
13 Participants
n=4 Participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race/Ethnicity, Customized
Other
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
4 Participants
n=4 Participants

PRIMARY outcome

Timeframe: VIsit 1/Day 1

Population: This analysis population includes all subjects randomized or assigned to study lenses as applicable, and exposed to study lenses including trial fit at Visit 1 (Full Analysis Set).

The Investigator used a multi-focal contact lens fitting guide to determine which study lens to fit

Outcome measures

Outcome measures
Measure
Alternative
n=198 Eyes
Bilaterally fitted with trial lenses using the alternative fitting guide
Current
n=166 Eyes
Bilaterally fitted with trial lenses using the current fitting guide
Mean Number of Trial Lenses Needed to Fit Each Eye
1.2 lenses
Standard Deviation 0.5
1.4 lenses
Standard Deviation 0.5

Adverse Events

AOA MF Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

AOA MF Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

DACP MF Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

DACP MF Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

DT1 MF Ocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

DT1 MF Nonocular

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Head, CDMA Vision Care Franchise

Alcon, A Novartis Division

Phone: 1-888-451-3937

Results disclosure agreements

  • Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
  • Publication restrictions are in place

Restriction type: OTHER